Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study


Tugal-Tutkun I., KADAYIFÇILAR S., Khairallah M., Lee S. C., Ozdal P., Ozyazgan Y., ...Daha Fazla

OCULAR IMMUNOLOGY AND INFLAMMATION, cilt.25, sa.1, ss.62-70, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 1
  • Basım Tarihi: 2017
  • Doi Numarası: 10.3109/09273948.2015.1092558
  • Dergi Adı: OCULAR IMMUNOLOGY AND INFLAMMATION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.62-70
  • Anahtar Kelimeler: Behcet's disease, uveitis, retinal vasculitis, interleukin-1 beta, gevokizumab, XOMA 052, ANTIBODY, INTERLEUKIN-1-BETA
  • İstanbul Üniversitesi Adresli: Evet

Özet

Purpose: To evaluate the safety and efficacy of gevokizumab for the treatment of Behcet's disease uveitis in a prospective, open-label, randomized phase 2 trial.